PEN
Penumbra, Inc.
NYSE · Healthcare · Medical - Devices · US
$322.17
+0.32%Margins
Gross margin
67.8%
EBITDA margin
14.8%
EBIT margin
12.4%
Net margin
10.7%
FCF margin
14.3%
10.5%
Return on equity
8.1%
Return on assets
10.7%
Return on invested capital
0.78x
Asset turnover
$277.8M
Cash from operations
$17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026